Ranibizumab is not bevacizumab for retinal vein occlusions

被引：0
|
作者：
Roberto Gallego-Pinazo
Rosa Dolz-Marco
Manuel Díaz-Llopis
机构：
[1] University and Polytechnic Hospital La Fe,Unit of Macula. Department of Ophthalmology
[2] University of Valencia,Faculty of Medicine
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2012年 / 250卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：955 / 956
页数：1
相关论文
共 50 条
  • [1] Ranibizumab is not bevacizumab for retinal vein occlusions
    Gallego-Pinazo, Roberto
    Dolz-Marco, Rosa
    Diaz-Llopis, Manuel
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 250 (07) : 955 - 956
  • [2] Bevacizumab and Ranibizumab for Macular Edema due to Retinal Vein Occlusions
    Niederhauser, N.
    Valmaggia, C.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2013, 230 (04) : 405 - 408
  • [3] Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial
    Vader, Maartje J. C.
    Schauwvlieghe, Ann-Sofie M. E.
    Verbraak, Frank D.
    Dijkman, Greetje
    Hooymans, Johanna M. M.
    Los, Leonoor, I
    Zwinderman, Aeilko H.
    Peto, Tunde
    Hoyng, Carel B.
    van Leeuwen, Redmer
    Vingerling, Johannes R.
    de Jong-Hesse, Yvonne
    van Lith-Verhoeven, Janneke J. C.
    Dijkgraaf, Marcel G. W.
    Schlingemann, Reinier O.
    OPHTHALMOLOGY RETINA, 2020, 4 (06): : 576 - 587
  • [4] Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical Practice
    Khan, Mehnaz
    Wai, Karen M.
    Silva, Fabiana Q.
    Srivastava, Sunil
    Ehlers, Justis P.
    Rachitskaya, Aleksandra
    Babiuch, Amy
    Deasy, Ryan
    Kaiser, Peter K.
    Schachat, Andrew P.
    Yuan, Alex
    Singh, Rishi P.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (06): : 465 - 472
  • [5] Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions
    Singer, Michael A.
    Cohen, Steven R.
    Groth, Sylvia L.
    Porbandarwalla, Salman
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1377 - 1383
  • [6] Comparing bevacizumab, ranibizumab, and aflibercept for early reduction of macular edema in patients with retinal vein occlusions (RVO).
    Jansen, Michael Eric
    Tyler, Lyndon
    Kermany, Daniel
    Waters, Jana
    Singer, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [7] Ranibizumab for serous macular detachment in branch retinal vein occlusions
    Gallego-Pinazo, Roberto
    Dolz-Marco, Rosa
    Pardo-Lopez, Diamar
    Martinez-Castillo, Sebastian
    Lleo-Perez, Antonio
    Arevalo, J. Fernando
    Diaz-Llopis, Manuel
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (01) : 9 - 14
  • [8] Ranibizumab for serous macular detachment in branch retinal vein occlusions
    Roberto Gallego-Pinazo
    Rosa Dolz-Marco
    Diamar Pardo-López
    Sebastián Martínez-Castillo
    Antonio Lleó-Pérez
    J. Fernando Arévalo
    Manuel Díaz-Llopis
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 9 - 14
  • [9] Results of bevacizumab as the primary treatment for retinal vein occlusions
    Figueroa, M. S.
    Contreras, I.
    Noval, S.
    Arruabarrena, C.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (08) : 1052 - 1056
  • [10] Variation in the use of bevacizumab and ranibizumab for branch retinal vein occlusion
    Yu, Fei
    Wu, Annie
    Wu, Connie
    Greenberg, Paul B.
    Lum, Flora
    Coleman, Anne
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
12345